NCI requests $591 million in additional funding for FY19

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NCI is asking for $6.38 billion for fiscal year 2019­—nearly $1 billion, or 12 percent, above FY17 appropriation levels—to fully fund promising research areas.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Matthew Bin Han Ong
Senior Editor

YOU MAY BE INTERESTED IN

Twenty years ago, the discovery of epidermal growth factor receptor mutations as drivers of tumorigenesis and viable targets for therapeutic intervention marked the beginning of a new era in lung cancer diagnosis and treatment. Since then, the field has made remarkable progress towards developing more effective targeted treatments and immunotherapies that have significantly improved patient outcomes and survival.
Matthew Bin Han Ong
Senior Editor

Login